2008 Keynote Speakers



ELIZABETH BARTLETT-FLURY
Director, Clinical Integration
Johns Hopkins Health System

JOHN C. LECHLEITER, Ph.D.
President and Chief Executive Officer
Eli Lilly and Company


flury ELIZABETH BARTLETT-FLURY
Director, Clinical Integration
Johns Hopkins Health System
 

In March 2008, Ms. Bartlett-Flury joined the executive management team of the Johns Hopkins Health System, an internationally recognized provider of unprecedented medical research, medical education and patient care located in Baltimore, MD.

Among her many responsibilities is to assist the Health System in developing and implementing a clinically integrated patient care delivery system as Johns Hopkins strives to redefine the standard for how health care will be delivered in the United States and maintain its rating as America’s #1 Best Hospital, an honor it has had for the past 18 consecutive years.


Prior to joining Johns Hopkins Health System, Ms. Bartlett-Flury was the national director of strategy, markets and governance in KPMG’s Health Care Advisory Services Practice, and served as KPMG’s U.S. Lead for Change Management. She has over twenty five years experience working in the health and senior care industries.   Ms. Bartlett-Flury has won national recognition for her leadership in defining consumer centered long term care.  She has spoken at numerous state, national and international forums on Changing Senior Markets: Implications and Opportunities, and is well published in the areas of leadership and the role of governance in health care. In addition to her industry experience, she has provided education and expert testimony at the U.S. Senate Committee on Aging hearings. Ms. Bartlett-Flury has a Master’s degree in Organizational Psychology and a B.S. in Business Administration.

Elizabeth resides in Annapolis, MD with her husband Craig, their five children and their newest "baby" - a Golden Retriever puppy named Sydney Bleu.

lechleiter
JOHN C. LECHLEITER, Ph.D.
President and Chief Executive Officer
Eli Lilly and Company


John C. Lechleiter, Ph.D, was named president and chief executive officer of Eli Lilly and Company in April 2008. He was named president and chief operating officer in 2005, when he also joined the company’s board of directors. Starting in January 2004, he had served as executive vice president, pharmaceutical operations.

Prior to that, he had been executive vice president for pharmaceutical products and corporate development since 2001. Lechleiter chairs the company’s operations committee, as well as its executive committee.

Lechleiter received a bachelor of science degree summa cum laude in chemistry from Xavier University (Cincinnati, Ohio) in 1975. He studied organic chemistry as a National Science Foundation Fellow at Harvard University, where he received his master’s and doctorate degrees. In 2006, Lechleiter received an honorary doctorate of business administration from Marian College of Indianapolis.

Joining Lilly in 1979 as a senior organic chemist in process research and development, Lechleiter became head of that department in 1982. In 1984, he began serving as director of pharmaceutical product development for the Lilly Research Centre Limited in Windlesham, England.

He returned to the United States in 1986 as manager of research and development projects for Europe. In 1988, he became director of development projects management, and in 1989 he assumed additional responsibility for pharmaceutical regulatory affairs. In 1991, he was named executive director of pharmaceutical product development, and in 1993, he became vice president. He was appointed vice president of regulatory affairs in 1994. In 1996, he was named vice president for development and regulatory affairs. Lechleiter became senior vice president of pharmaceutical products in 1998.

Lechleiter is a member of the American Chemical Society. He serves as a member of the executive committee of the board of directors of Pharmaceutical Research and Manufacturers of America (PhRMA) and as a member of the Business Roundtable and the Business Council. In 2004, he was appointed to the Visiting Committee of Harvard Business School and to the Health Policy and Management Executive Council of the Harvard School of Public Health. He also serves as a member of the board of trustees of Xavier University (Cincinnati, Ohio). In addition, he is a distinguished advisor of The Children’s Museum of Indianapolis, a member of the board of directors and executive committee of Fairbanks Institute, and a member of the United Way of Central Indiana board of directors. He also serves on the board of Indianapolis Downtown, Inc.